Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects and consequences for mother and child from treatment for depression
2013-004444-31Phase 4Terminated
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing ICBT + sertraline with ICBT + placebo (2 arms). Primary endpoint: Primary: Child cognitive development at 2 years. Started Jan 2015; status: terminated.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2013-004444-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004444-31.